|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 31/4412 | (2006.01) |
| A61P 11/00 | (2006.01) |
| (11) | Number of the document | 2308491 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10250378.6 |
| Date of filing the European patent application | 2010-03-03 | |
| (97) | Date of publication of the European application | 2011-04-13 |
| (45) | Date of publication and mention of the grant of the patent | 2011-09-07 |
| (46) | Date of publication of the claims translation | 2011-10-14 |
| (30) | Number | Date | Country code |
| 266753 P | 2009-12-04 | US | |
| 684543 | 2010-01-08 | US |
| (72) |
Bradford, Williamson Ziegler, US
Szwarcberg, Javier, US
|
| (73) |
Intermune, Inc.,
1 DNA Way, South San Francisco, CA 94080,
US
|
| (74) |
Ramunė GARŠVIENĖ,
Dūkštų g. 28-20, LT-07171 Vilnius,
LT
|
| (54) | Pirfenidono terapija ir citochromo P450 induktoriai |
| Pirfenidone therapy and inducers of cytochrome P450 |
| Payment date | Validity (years) | Amount | |
| 2023-02-23 | 14 | 289.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2024-03-03 |